Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH To Fund Three Robotic Projects To Improve Health And Quality Of Life

Executive Summary

The National Institutes of Health (NIH) plans to provide $2.2 million in funding over the next five years for the development of three innovative "co-robot" projects: an affordable hand-worn device to help the visually impaired grasp objects, a smart-walker to increase mobility in the elderly and a social-robot companion for children. The hand-worn device, which can detect a small object and help the blind user maintain alignment with the object while approaching it, has a global market potential of nearly $20 billion.

You may also be interested in...



Health And Wellness Weekly Trademarks Review: 207February

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Cosmetic And Personal Care Trademark Review: 27 February

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Herbalife Executives' Investments Spark Uptick In Share Price After Results Send Stock Plummeting

Since closing at a 14-year low of $8.07 the day of the execs’ transactions, Herbalife shares trend steadily up from close of $8.26 on 20 February to $8.83 on 29 February. Some execs sell back some shares on 25 February at $8.67.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel